Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 100
Inclusion Criteria
- Patients with soft tissue sarcoma with at least one pulmonary metastasis
- Metastatic lung disease must have been present at time of initial presentation
- Patients with soft tissue sarcoma with at least one pulmonary metastasis
- Metastatic lung disease must have been present at time of initial presentation
Exclusion Criteria
- Patients who have been previously undergone surgical resection of the primary tumor
- All patients under 18 will be excluded
- Patients who have been previously undergone surgical resection of the primary tumor
- All patients under 18 will be excluded
Summary
- Conditions
- Metastatic Lung Disease
- Soft Tissue Sarcoma
- Type
- Observational
- Design
- Observational Model: Case-Control
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Patients with soft tissue sarcoma with at least one pulmonary metastasis
- Metastatic lung disease must have been present at time of initial presentation
- Patients with soft tissue sarcoma with at least one pulmonary metastasis
- Metastatic lung disease must have been present at time of initial presentation
Exclusion Criteria
- Patients who have been previously undergone surgical resection of the primary tumor
- All patients under 18 will be excluded
- Patients who have been previously undergone surgical resection of the primary tumor
- All patients under 18 will be excluded
Tracking Information
- NCT #
- NCT02080897
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: William Eward, MD Duke University
- William Eward, MD Duke University
Get Well Soon